A voluntary recall issue has been served for a popular La Roche-Posay product in the US after it was found among 66 leading ...
Sandoz said it expects net sales to grow by a mid-single digit percentage in constant currencies in 2025. Image credit: Shutterstock/ T. Schneider. Sandoz reported a 9% growth in net sales of generics ...
Here’s how it works. I've been testing the best workout headphones for almost a decade, and know that the difference between a good and a great set is how well they stay in place during fast ...
But a Melbourne-based Avecho Biotechnology has turned regulation to its advantage, signing a deal with ₣17 billion ($30 billion) Swiss pharma company Sandoz that could potentially be worth more than ...
Please view our affiliate disclosure. Artificial intelligence is revolutionizing the fitness industry by offering personalized workout experiences right at our fingertips. AI-powered workout apps and ...
'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...
Healthline looked high and low for the best fitness apps to help you out. We chose these apps for their quality, user reviews, and overall reliability. Here are our picks for the 10 best fitness ...
Dividend Yield 5 Year Avg.
(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group. The Sandoz Family Foundation, through the vehicle Emasan AG, is offering 26.5 ...
ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis, the bookrunner on the deal ...
ZURICH, Feb 26 (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis (NOVN.S), opens new tab ...
Samsung Bioepis launched this product, under the brand name Pyzchiva, in the US earlier this week with partner Sandoz. Despite the contract not permitting Samsung to sub-license its rights for an ...